XEN® Gel Stent is appropriate to lower intraocular pressure (IOP) for indicated refractory glaucoma patients1:
Pseudophakic (with or without prior MIGS*)
John: Pseudophakic
Age: 70
IOP: 25 mm HG OD; 18 mm Hg OS
Uncontrolled on 2 drops
No longer a candidate for MIGS due to previous cataract surgery
Uncontrolled on maximum tolerated medical therapy
Maxine: uncontrolled on maximum tolerated medical therapy
Age: 57
IOP: 25 mm Hg OD; 29 mm Hg OS
Uncontrolled on 2 drops (3 medications total)
Not a candidate for cataract surgery
Inadequately controlled by prior surgery, including MIGS*
Steven: Prior MIGS*
Age: 64
IOP 31 mm Hg OD; 24 mm Hg OS
Uncontrolled with prior surgery
Undergoing cataract surgery (can be performed in combination with XEN®)
Candace: Needs cataract surgery
Age: 69
IOP: 24 mm Hg; 27 mm Hg OS
Uncontrolled on 3 drops
XEN® in combination with cataract surgery
*In the clinical study, prior surgery only included trabeculectomy, tube shunt, canaloplasty, selective laser trabeculoplasty (SLT), and trabeculotomy.1
XEN® Gel Stent has demonstrated efficacy as a stand-alone procedure or in conjunction with cataract surgery.1,10